Emerald Health Therapeutics (CVE:EMH) Trading Up 5.9%

Emerald Health Therapeutics Inc (CVE:EMH)’s share price was up 5.9% during mid-day trading on Friday . The stock traded as high as C$0.18 and last traded at C$0.18, approximately 235,887 shares changed hands during mid-day trading. A decline of 71% from the average daily volume of 818,643 shares. The stock had previously closed at C$0.17.

The company has a quick ratio of 0.08, a current ratio of 0.59 and a debt-to-equity ratio of 26.61. The stock has a market cap of $34.02 million and a price-to-earnings ratio of -0.25. The company’s 50-day simple moving average is C$0.22 and its 200-day simple moving average is C$0.24.

Emerald Health Therapeutics (CVE:EMH) last posted its quarterly earnings results on Thursday, May 14th. The company reported C($0.16) earnings per share (EPS) for the quarter. The business had revenue of C$4.94 million for the quarter. As a group, analysts expect that Emerald Health Therapeutics Inc will post -0.21 EPS for the current fiscal year.

About Emerald Health Therapeutics (CVE:EMH)

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis in Canada. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Victoria, Canada.

Read More: Trade Deficit

Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.